Indefinite Delivery Contract 75F40123D00021
Active Awarded Last action
- Contract number
- 75F40123D00021
- Awardee
-
Kaiva Strategies, LLC UEI HCWKVFGBPA64
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Task orders
- 39 $65,154,896 obligated
Award facts
- Combined order value
-
- $65,154,896 Current, with exercised options
- $106,673,373 Potential, with all options
- Last date to order 64% complete
- IDV ceiling 65% used
- $100,000,000.00
- Maximum order
- $100,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Competitive 8(a)
- Competition
- Full and Open Competition after exclusion of sources · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Health and Human Services Food and Drug Administration (FDA) awarded a single-award Indefinite Delivery Contract (IDC) worth up to $100 million to Kaiva Strategies, LLC, a tribally-owned, minority-owned small business. The IDC is set aside for competitive 8(a) businesses and will run through August 2028. Under this IDC, the FDA has issued a $2.3 million task order for Kaiva Strategies to provide professional, administrative, and consulting services support, to be performed in Silver Spring, Maryland over a five-year period ending in September 2028. Kaiva Strategies specializes in offering a wide range of services to federal health agencies, including medical writing, scientific writing, editing, program management, regulatory science communication, data analysis, and public health infrastructure support. The company has delivered these services across multiple FDA offices and centers, supporting the agency's critical public health missions.
Task orders
Show all 39
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75F40123D00021?
75F40123D00021 was awarded to Kaiva Strategies, LLC by Food and Drug Administration (Department of Health and Human Services) on August 14, 2023.
How much is contract 75F40123D00021 worth?
Orders under 75F40123D00021 have obligated $65,154,896. Their combined potential value, with all options, is $106,673,373. 75F40123D00021's own ceiling is $100,000,000. A single order can be worth up to $100,000,000.
How many orders have been placed under contract 75F40123D00021?
39 orders have been placed under 75F40123D00021, the latest on September 30, 2026.
Who can order from contract 75F40123D00021?
75F40123D00021 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75F40123D00021 competed?
The extent of competition for 75F40123D00021 was full and open competition after exclusion of sources. The government received 5 offers. It was set aside: Competitive 8(a).
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV